共 533 条
- [1] Horst B(2009)Comparison of drug-eluting and bare-metal stents for stable coronary artery disease JACC Cardiovasc Interv 2 321-328
- [2] Rihal CS(2007)Outcomes associated with drug-eluting and bare-metal stents: a collaborative network metaanalysis Lancet 370 937-948
- [3] Holmes DR(2004)A hierarchical Bayesian meta-analysis of randomized clinical trials of drug-eluting stents Lancet 364 583-591
- [4] Bresnahan JF(2004)Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 1930-1932
- [5] Prasad A(2006)Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 193-202
- [6] Gau G(2004)Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 701-705
- [7] Lennon R(2007)Pathological correlates of late drugeluting stent thrombosis: strut coverage as a marker of endothelialization Circulation 115 2435-2441
- [8] Lerman A(2008)Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V) Vasc Health Risk Manag 4 31-38
- [9] Stettler C(2006)A randomized comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent: the SPIRIT II trial EuroIntervention 2 286-294
- [10] Wandel S(2011)Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trials JACC Cardiovasc Interv 4 1104-1115